I-KaiBiLi Flu&Covid-19 Antigen Duo Rapid Test
Isingeniso
Izimpawu zomtholampilo nezimpawu zokutheleleka ngegciwane lokuphefumula ngenxa ye-SARS-CoV-2 kanye nomkhuhlane zingafana.I-SARS-CoV-2, i-influenza A kanye nama-antigens wegciwane lomkhuhlane B ngokuvamile atholakala ezibonelweni eziphezulu zokuphefumula ngesikhathi sesigaba esibi kakhulu sokutheleleka.
Igciwane lomkhuhlane lingelomndeni we-Orthomyxoviridae, kanye ne-immunologically ehlukahlukene, amagciwane e-RNA anomucu owodwa.Kukhona igciwane lomkhuhlane A no-B yilona gciwane elidala izifo ezinzima kubantu nasezinhlotsheni eziningi zezilwane.Ngokusekelwe ophenyweni lwamanje lwe-epidemiological, isikhathi sokufukamela siyizinsuku ezi-1 kuya kwezi-4.Izimpawu eziyinhloko zihlanganisa imfiva enzima, ukuqaqamba okujwayelekile kanye nezimpawu zokuphefumula.Womabili amagciwane oHlobo A no-B angajikeleza kanyekanye, kodwa ngokuvamile uhlobo olulodwa lunamandla phakathi nenkathi ethile yonyaka.1
I-COVID-19 yisifo esithathelwanayo sokuphefumula esinamandla.Ngokuvamile abantu bayathinteka.Njengamanje, iziguli ezingenwe yi-coronavirus yenoveli ziwumthombo oyinhloko wokutheleleka;abantu abane-asymptomatic abangenwe yileli gciwane bangaba umthombo othathelwanayo.Ngokusekelwe ophenyweni lwamanje lwe-epidemiological, isikhathi sokufukamela siyizinsuku ezi-1 kuya kweziyi-14, izikhathi eziningi izinsuku ezi-3 kuya kweziyi-7.Izimpawu eziyinhloko zihlanganisa umkhuhlane, ukukhathala nokukhwehlela okomile.Ukucinana kwamakhala, ikhala eligijimayo, umphimbo obuhlungu, i-myalgia kanye nesifo sohudo kutholakala ezimweni ezimbalwa.
KaiBiLiTMI-Flu & COVID-19 Antigen Duo Rapid Test ihloselwe ukutholwa kwekhwalithi kanye kanye nokuhlukaniswa kwama-nucleocapsid protein antigens asuka kwa-SARS-CoV-2, umkhuhlane A kanye nomkhuhlane B ezifanekisweni eziqondile ze-nasopharyngeal (NP).Ukutholwa kusekelwe kumasosha omzimba athuthukiswe abona futhi asabela nge-nucleoprotein yegciwane.
Ukutholwa
KaiBiLiTMI-Flu & COVID-19 Antigen Duo Rapid Test iwukutholwa kwekhwalithi kanye kanye nokwehlukaniswa kwama-nucleocapsid protein antigens asuka kwa-SARS-CoV-2, umkhuhlane A kanye nomkhuhlane B emifanekisweni eqondile ye-nasopharyngeal (NP).
Isifanekiso
I-Nasopharyngeal
Umkhawulo Wokutholwa (LoD)
I-SARS-CoV-2 & Flu: 140 TCID50/mL
Umkhuhlane A
| I-Influenza Viral Strain | I-LOD ebaliwe (TCID50/mL) |
| A/New Caledonia/20/1999_H1N1 | 8.50x103 |
| A/California/04/2009_H1N1 | 2.11x103 |
| A/PR/8/34_H1N1 | 2.93x103 |
| A/Bean Goose/Hubei/chenhu XVI35-1/2016_H3N2 | 4.94x102 |
| A/Guizhou/54/89_H3N2 | 3.95x102 |
| A/Human/Hubei/3/2005_H3N2 | 2.93x104 |
| I-A/Bar-headed Goose/QH/BTY2/2015_H5N1 | 1.98x105 |
| A/Anhui/1/2013_H7N9 | 7.90x105 |
Umkhuhlane B.
| I-Influenza Viral Strain | KubaliweLOD(I-TCID50/mL) |
| B/Victoria | 4.25x103 |
| B/Yamagata | 1.58x102 |
Ukunemba
| Umkhuhlane A | Umkhuhlane B | i-COVID-19 | |
| Ukuzwela Okuhlobene | 86.80% | 91.70% | 96.60% |
| Ukucaciswa Okuhlobene | 94% | 97.50% | 100% |
| Ukunemba | 92.20% | 96.10% | 98.90% |
Isikhathi Semiphumela
Funda imiphumela ngemizuzu eyi-15 futhi ungabi ngaphezu kwemizuzu engama-30.
Izimo zokugcina ikhithi
2~30°C.
Okuqukethwe
| Hlola amadivayisi | Izivivinyo ezingu-20 |
| Ama-swabs afakwe inzalo | 20 ama-pcs. |
| Amashubhu okukhipha (enebhafa yokukhipha engu-0.5mL) | 20 ama-pcs. |
| Imbobo enesihlungi | 20 ama-pcs. |
| I-Tube Stand | 1 ama-pcs. |
| Faka Iphakheji | 1 ama-pcs. |
Uku-oda Ulwazi
| Umkhiqizo | Ikati.No. | Okuqukethwe |
| KaiBiLiTMUmkhuhlane kanye ne-COVID-19 Antigen Duo | P211137 | 20 Ukuhlolwa |
